DNA-PK-IN-3 is a potent DNA-PK inhibitor that synergistically enhances the efficacy of radiotherapy and chemotherapy, effectively inhibits tumor growth, and significantly reduces damage to normal cells, thereby minimizing side effects; it holds potential for cancer research.